🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a dose-seeking and efficacy study of combined BRAF Inhibitor Vemura...
Status
Completed
Location
Hillman Cancer Center
Start Date
2013-10
Trial ID
NCT01943422
Treatments Being Tested
The purpose of this study is to establish if BMS-986202 is safe and effecti...
Status
Completed
Location
Local Institution
Start Date
2016-05-18
Trial ID
NCT02763969
Treatments Being Tested
This phase I trial is studying the side effects of decitabine when given to...
Status
Terminated
Location
Nevada Cancer Institute-Summerlin Campus
Start Date
2009-04
Trial ID
NCT00701298
Treatments Being Tested
To estimate the difference in efficacy and safety of bevacizumab and RAD001...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2008-11-12
Trial ID
NCT00719264
Treatments Being Tested
The purpose of the study is to compare the efficacy and toxicity including ...
Status
Completed
Location
Dept of Hematology, Aalborg hospital
Start Date
2012-01
Trial ID
NCT01387763
This is a feasibility study in patients with localized or metastatic soft t...
Status
Completed
Location
Monter Cancer Center (Northwell Health)
Start Date
2016-12-15
Trial ID
NCT03056599
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2002-04
Trial ID
NCT00045370
Treatments Being Tested
The primary purpose of this research study is to test the safety and possib...
Status
Withdrawn
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2023-07
Trial ID
NCT05729139
Treatments Being Tested
RATIONALE: Interferon alfa may interfere with the growth of tumor cells and...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2005-02
Trial ID
NCT00278174
Treatments Being Tested
Phase II trial to study the effectiveness of combining interleukin-12 and i...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
2001-10
Trial ID
NCT00026143
Treatments Being Tested